EHA 2026 | Age and cytogenetics influence prognostic value of copy number profiles in B-cell ALL
Anthony Moorman, PhD, Newcastle University, Newcastle, UK, discusses findings from a large HARMONY Alliance analysis exploring how age and cytogenetic risk influence the prognostic value of copy number alteration profiles in B-cell acute lymphoblastic leukemia (ALL). Prof. Moorman highlights how biomarkers derived from pediatric ALL are often less predictive in adult disease, underscoring the need for age-specific risk models and more comprehensive approaches to risk stratification beyond single biomarkers. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
